-
The Big Idea Behind Big Data
Nov 17, 2017, 11:14 AM by Michael CroftNPR.org | As we find our way in a world shaped by Big Data, it's not the reams of information we gather but the networks they illuminate that's the newest addition to science's index of things.Full story -
In Search For Alzheimer's Drugs, Researchers Must Go Beyond Beta Amyloid
Nov 17, 2017, 09:47 AM by Michael CroftSTAT | In the search for Alzheimer's drugs, it's time to pay more attention to drugs that go beyond targeting beta amyloid, a protein linked to the disease.Full story -
Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience
Nov 17, 2017, 04:33 AM by Michael Croft- Nov 17, 2017 - November 16, 2017, Oxford, England and San Francisco, Calif. - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNAFull story -
Creative Enzymes Released Newly-updated Products
Nov 16, 2017, 22:42 PM by Michael CroftSHIRLEY, NY - Nov 17, 2017 - November, 15th, 2017, as an experienced supplier and manufacturer in enzyme field in USA, Creative Enzymes adds three products belonging to hydrolases, food & beverage and oxidoreductases separatelyFull story -
MasterControl Launches Version 11.7, Provides Enhanced Analytics Capabilities and Robust Clinical and Regulatory Solutions
Nov 16, 2017, 13:20 PM by Michael CroftSALT LAKE CITY, UT, UNITED STATES - Nov 16, 2017 - MasterControl Inc., a leading global provider of software solutions that enable life science and other regulated companies to deliver life-improving products to more people sooner, today announced it has released MasterControl Version 11Full story -
WIRB-Copernicus Group Partners with Veeva Systems Inc.
Nov 16, 2017, 08:19 AM by Michael CroftPRINCETON, NJ - Nov 16, 2017 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems IncFull story -
Drug Development: Making the impossible possible
Nov 16, 2017, 04:34 AM by Michael Croft- Nov 16, 2017 - THE Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural eventFull story -
African scientists get their own open-access publishing platform
Nov 15, 2017, 12:55 PM by Michael CroftNature News & Comment | Venture will launch next year and seeks to strengthen continent's science by helping academics share work more quickly.Full story -
US Scientists Try 1st Gene Editing In The Body
Nov 15, 2017, 11:08 AM by Michael CroftAP News | Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease.Full story -
Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx And Expanded Use Of MiSeqDx
Nov 15, 2017, 10:35 AM by Michael CroftBio-IT World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.Full story -
Immuno-oncology CRO secures Macrophage Pharma agreement
Nov 15, 2017, 06:30 AM by Michael Croft- Nov 10, 2017 - Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma LtdFull story -
Genomics’ Role In Global Pathogen Surveillance, Diagnosis
Nov 14, 2017, 10:05 AM by Michael CroftFull storyBio-IT World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.
-
FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses
Nov 14, 2017, 09:44 AM by Michael CroftPRINCETON, NJ - Nov 14, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certaras PBPK Simcyp® Population-based Simulator and its Pediatric and Cardiac Safety SimulatorsFull story -
Wiping Out Alzheimers Is Personal To Microsofts Bill Gates And Paul Allen
Nov 13, 2017, 17:36 PM by Michael CroftForbes | Bill Gates announced today that he will invest $50 million of his own money in the Dementia Discovery Fund. Gates has a different approach to funding Alzheimer's research than does Allen, his Microsoft co-founder, but the two are similar in their motives and beliefs about what it's going to take to conquer the disease.Full story -
America Just Can’t Match China’s Exploding Supercomputing Power
Nov 13, 2017, 13:10 PM by Michael CroftMIT Technology Review | What's up in emerging technology, including China's exploding supercomputing power.Full story -
Transforming Information Into Knowledge In The Big Data Era
Nov 13, 2017, 11:20 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Despite the overwhelming volume and complexity of scientific literature, and the myriad ways of accessing and managing it, the success of an entire research organization may depend on quick, efficient, cost-effective, and unfettered access to the information contained in reference publications. So, how do biomedical and drug discovery researchers effectively transform information into useful knowledge in the Big Data era?
-
Bio-Optronics® and Complion Announce Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations
Nov 13, 2017, 09:39 AM by Michael CroftROCHESTER, NY - Nov 13, 2017 - Bio-Optronics, the makers of the market leader Clinical Conductor Clinical Trial Management System (CTMS), and Complion, the powerful eRegulatory and document management platform for sites, have partnered to integrate their best-in-class solutions to deliver an industry-leading solution for research organizationsFull story -
Aircuity Announces its Airside Efficiency Platform to improve energy efficiency and indoor environmental quality
Nov 9, 2017, 15:38 PM by Michael CroftNEWTON, MA, UNITED STATES - Nov 9, 2017 - Aircuity, maker of smart automated airside solutions, announces that its airside efficiency platform has been included in a major retrofit project by the National Research Council of Canada (NRC)Full story -
Struggling GSK Recruits Cancer Drug Guru Hal Barron As Its New R&D Chief
Nov 9, 2017, 13:05 PM by Michael CroftENDPOINTS | GlaxoSmithKline has recruited Hal Barron, one of the world's top cancer drug investigators, to take the helm of its troubled pharma R&D group, offering a fresh sign that the pharma giant is jumping back in a big way into oncology.Full story -
DuraTherm PLUS+ is an ISTA-validated shipping solution for temperature-sensitive payloads
Nov 9, 2017, 11:04 AM by Michael CroftDENVER, CO, UNITED STATES - Nov 9, 2017 - Denver, CO - ACH Foam Technologies announces DuraTherm PLUS+™, an advanced cold chain shipping solution that assures payload temperatures remain between 2⁰ to 8⁰ Celsius for a 24-hour delivery windowFull story